| |
| |
|
| Insider
Information: |
Pacelli Steven Robert |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
142,975 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,819,527 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,975 |
|
|
| Total
Value |
$14,819,527 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 44.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
EVP Managing Director ... |
2023-11-24 |
124,775 |
2008-11-19 |
0 |
Premium* |
|
|
Prosomnus, Inc. |
OSA |
|
2022-12-06 |
18,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
216 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-10-23 |
4 |
AS |
$151.69 |
$233,435 |
D/D |
(1,532) |
80,751 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-09-23 |
4 |
AS |
$155.11 |
$238,181 |
D/D |
(1,532) |
82,283 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-03-23 |
4 |
AS |
$207.17 |
$320,335 |
D/D |
(1,531) |
80,532 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-12-23 |
4 |
AS |
$213.10 |
$326,576 |
D/D |
(1,532) |
77,687 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2019-11-22 |
4 |
AS |
$217.39 |
$333,300 |
D/D |
(1,532) |
79,219 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-01-23 |
4 |
AS |
$233.17 |
$358,971 |
D/D |
(1,532) |
76,155 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-03-11 |
4 |
S |
$246.25 |
$2,131,534 |
D/D |
(8,049) |
84,313 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-02-24 |
4 |
AS |
$275.76 |
$425,323 |
D/D |
(1,531) |
74,624 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Managing Director Dexcom V |
• – – |
2022-05-24 |
4 |
AS |
$296.33 |
$74,083 |
D/D |
(250) |
35,175 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-04-23 |
4 |
AS |
$318.57 |
$487,731 |
D/D |
(1,531) |
79,001 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-11-23 |
4 |
AS |
$318.99 |
$344,190 |
D/D |
(1,079) |
60,860 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-05-24 |
4 |
AS |
$343.73 |
$376,260 |
D/D |
(1,079) |
52,321 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2021-03-23 |
4 |
AS |
$352.88 |
$388,967 |
D/D |
(1,079) |
54,479 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-12-23 |
4 |
AS |
$357.95 |
$388,276 |
D/D |
(1,079) |
59,781 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2021-03-10 |
4 |
S |
$362.92 |
$2,019,996 |
D/D |
(5,566) |
55,558 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2021-01-22 |
4 |
AS |
$367.47 |
$397,960 |
D/D |
(1,079) |
58,702 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2022-02-23 |
4 |
AS |
$394.33 |
$98,583 |
D/D |
(250) |
34,370 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-09-23 |
4 |
AS |
$395.11 |
$426,324 |
D/D |
(1,079) |
67,218 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-05-22 |
4 |
AS |
$396.74 |
$607,409 |
D/D |
(1,531) |
77,470 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-10-23 |
4 |
AS |
$397.49 |
$435,030 |
D/D |
(1,079) |
61,939 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-09-09 |
4 |
S |
$398.30 |
$1,824,223 |
D/D |
(4,580) |
68,297 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-09-25 |
4 |
AS |
$400.07 |
$800,137 |
D/D |
(2,000) |
65,218 |
0 |
% |
|
| DXCM |
DexCom Inc |
Managing Dir., Dexcom Ventures |
• – – |
2022-03-09 |
4 |
D |
$406.06 |
$1,392,368 |
D/D |
(3,429) |
35,925 |
0 |
- |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2021-02-23 |
4 |
AS |
$406.98 |
$439,131 |
D/D |
(1,079) |
55,823 |
0 |
% |
|
| DXCM |
DexCom Inc |
EVP Strategy and Corporate Dev |
• – – |
2020-06-23 |
4 |
AS |
$407.18 |
$626,750 |
D/D |
(1,531) |
75,939 |
0 |
% |
|
216 Records found
|
|
Page 8 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
